Abstract: Methods and systems for semiconductor testing are disclosed. In one embodiment, devices which are testing too slowly are prevented from completing testing, thereby allowing untested devices to begin testing sooner.

Abstract: The present invention provides a method of predicting the risk of a patient for developing adverse drug reactions, particularly SJS or TEN. It was discovered that an HLA-B allele, HLA-B* 1502, is associated with SJS/TEN that is induced by a variety of drugs. The correlation with HLA-B* 1502 is most significant for carbamazepine-induced SJS/TEN, wherein all the patients tested have the HLA-B* 1502 allele. In addition, another HLA-B allele, HLA-B*5801, is particularly associated with SJS/TEN induced by allopurinol. Milder cutaneous reactions, such as maculopapular rash, erythema multiforme (EM), urticaria, and fixed drug eruption, are particularly associated with a third allele, HLA-B *4601. For any of the alleles, genetic markers (e.g., HLA markers, microsatellite, or single nucleotide polymorphism markers) located between DRB1 and HLA-A region of the specific HLA-B haplotype can also be used for the test.

Abstract: An apparatus for attaching an extraneous item to a military uniform is disclosed. The apparatus for attaching an extraneous item to a military uniform, which can attach a name tag, a unit marking, insignia of rank, etc. to a predetermined position of the military uniform, includes: a female Velcro tape where an attaching means is formed; an attaching member which is formed with the same size as the female Velcro tape and has the same pattern or color as the military uniform formed on the surface and a male Velcro tape formed on the back side; and an extraneous item comprising a name tag, a unit marking, insignia of rank, etc. to be attached to the surface of the attaching member.

Abstract: A system for converting wind and solar energy for use with an electrical generator, the system includes a wind powered subsystem including: a rotor for receiving wind to generate mechanical energy; and a first shaft for providing a permanent mechanical coupling between the rotor and the electrical generator for transferring the generated mechanical energy to the electrical generator; a solar powered subsystem including: a solar collector for receiving solar energy to generate thermal energy; a thermo-mechanical engine coupled to the solar collector for converting the generated thermal energy into mechanical energy; and a second shaft mechanically coupled to the thermo-mechanical engine; and an interconnection subsystem for selecting between coupling the second shaft to the first shaft for combining the mechanical energy generated by the wind and solar powered subsystems to be transferred to the electrical generator, and decoupling the second shaft from the first shaft.

Abstract: Methods, systems, and apparatus, including computer program products, for processing read and write requests received from a cloned instance of a server application, the cloned instance of the server application having a corresponding instance that is hosted in a production portion of a computing environment.

Abstract: The invention relates to a device (100) for treating wounds of the human or animal body using a vacuum and having a gas-tight wound-covering element (4), which, when placed in contact with the body of the patient, forms a wound space (10) between the respective wound and the wound-covering element, at least one connecting site (5.1; 5.2), which is in contact with the wound space (10), an absorption body (2), which is a layer, enclosed in an envelope, of a textile section, interspersed with super-absorbing particles, the envelope being permeable to liquids and having pores, the size of which does not exceed that of the super-absorbing particles.

Abstract: A method for providing relief from Meniere's disease, includes reversibly disabling vestibular function following detection of an attack of Meniere's disease following detection of an attack of Meniere's disease.

Abstract: A method for skin care includes administering the water insoluble fraction of Astragalus membranaceus, or astragaloside compounds thereof to a subject in need thereof at an effective amount for improving skin texture, reducing wrinkles, UV protection, and/or providing an anti-aging effect.

Abstract: An modified peptide of human acidic fibroblast growth factor (aFGF), comprising a native human aFGF shortened by a deletion of a deletion of 20 amino acids from N-terminal of the native human aFGF, and an addition of Alanine (Ala) before the shortened native aFGF is provided.

Abstract: The present invention provides a method for enhancing the immune function of leukocytes in a subject, which comprises the steps of: (a) isolating leukocytes from the subject; (b) treating the leukocytes obtained from step (a) with an inhibitor of the endoplasmic reticulum calcium ion pump; and (c) administrating the treated leukocytes obtained from step (b) back to the subject. A pharmaceutical composition for enhancing the immune function of leukocytes in a subject and a method for preparing said pharmaceutical composition are also provided.

Abstract: The present invention relates to a novel promoter and its use in driving expression of foreign genes in transgenic animals (especially pigs). Accordingly, the present invention provides a method for producing transgenic animals harboring heterologous genes regulated by the promoter of the present invention.

Abstract: This invention relates to processing of audio files, and more specifically, to an improved technique of searching audio. More particularly, a method and system for processing audio using a multi-stage searching process is disclosed.

Abstract: A supplement to be administered enterally to maintain or restore the intestinal intestinal barrier of the critically or chronically ill and people with malnutrition is described. This contains as solution, in each case based on a daily dose, a) glutamine and/or glutamine precursors in an amount in the range from 15 to 70 g, b) at least two representatives from the group of substances having antioxidant activity, and c) short-chain fatty acids and/or precursors of short-chain fatty acids in an amount of from 0.5 to 10 g.

Abstract: A method for fetal monitoring includes acquiring electrical signals from a set of electrodes, for example, a set of surface electrodes applied to a maternal abdominal region. The electrical signals are analyzed, including by performing a morphological analysis of fetal electrocardiogram signals. A clinical indicator is then determined from a result of performing the morphological analysis.

Abstract: This invention relates to a method of determining the presence of certain HLA alleles, such as HLA-B*1502 or HLA-B*5801, and a kit for carrying out this method. Also disclosed is a method for assessing whether a patient is at risk for developing adverse drug reactions (e.g., Stevens-Johnson syndrome, toxic epidermal necrolysis, or hypersensitivity syndrome) based on the presence or absence of a genetic marker (e.g., HLA-B*1502, HLA-B*5801, or HLA-B*4601).

Abstract: Cellular receptors are identified that induce plasma leakage and other negative effects when infected with flaviviruses, such as dengue virus or Japanese encephamyelitis virus. Using fusion proteins disclosed herein, the receptors to which a pathogen, such as flavivirus, binds via glycan binding are determined. Once the receptors are determined, the effect of binding to a particular receptor may be determined, wherein targeting of the receptors causing a particular symptom may be targeted by agents that interrupt binding of the pathogen to the receptor. Accordingly, in the case of dengue virus and Japanese encephamyelitis virus, TNF-? is released when the pathogen binds to the DLVR1/CLEC5A receptor. Interrupting the DLVR1/CLEC5A receptor with monoclonal antibodies reduced TNF-? secretion without affecting secretion of cytokines responsible for viral clearance thereby increasing survival rates in infected mice from nil to around 50%.

Abstract: This invention provides a nacelle of a wind energy converter and a corresponding mounting method of a nacelle of a wind energy converter and a generator for a wind energy converter. The nacelle includes a main frame; a generator including a stator and a rotor; a generator housing attached to the main frame and at least partially enclosing the stator and a rotor space; wherein the generator housing (20; 20?) has a first and second side face (S1, S2); wherein the first side face (S1) of the generator housing (20; 20?) exposes the rotor space (21); and a flange rotatably supported on the main frame and having a first end which is connected to the rotor; wherein the rotor extends into the rotor space (25) from the first side face (S1) without being supported in the generator housing.

Abstract: A system for providing reactive power compensation to a utility power network includes a switch coupled to the utility power network, and a capacitor coupled with the switch for providing a controlled amount of reactive current based on conditions of the utility power network. The system also includes a switchable power dissipation device coupled in series to the capacitor and configured to provide a preselected amount of impedance to the reactive current for a predetermined duration when a line voltage on the utility power network drops below a threshold.

Abstract: Imidazolidinone and imidazolinethione compounds of formula (I): wherein R1, R2, R3, A1, A2, X, Y, Z, m, n, p, x, and y are defined herein. Also disclosed is a method of treating hepatitis C virus infection with these compounds.

Abstract: According to a process for manufacturing a series of ophthalmic lenses, each lens consists of a substrate and a film portion (3) attached to the substrate. The characteristics specific to each lens are obtained by functionalizing the film portion. Film functionalization is carried out when the film is in the form of a large planar sheet (2), and then each portion is cut from the sheet. To obtain economic lens manufacture, with a good production yield, the film portions have, right from the start of the process, dimensions corresponding substantially to the housing of a frame into which each lens is intended to be fitted.